Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: 25 | Mind Blowing Facts

Banks drag back early gains as local shares edge higher

The Australian share market has given up more than half its early session gains but finished slightly higher, after a dramatic about-face in financials stocks.

AAP

Man who claimed Roundup caused his cancer awarded $2.1billion

The verdict marks the latest in a long-running series of court battles Monsanto has faced over its Roundup herbicide

The Independent UK

AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing

Pharma company will invest money over five years in ‘strategic partnership’ after ditching UK expansion

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

UK pharmacies could cut hours unless NHS provides ‘new and sufficient’ funding

The National Pharmacy Association has recommended collective action for the first time in its history

The Guardian - UK

AMD manager reports 45% GPU retail market share in Japan — Eyes 70% as the next target

AMD marketing manager Yoshiaki Sato reported that Radeon GPUs have accounted for 45% of GPU sales in Japan, presumably since RDNA 4 launched.

Tom’s Hardware

AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy’

UK pharma group acquires Belgium’s EsoBiotec as it announces EU has approved Imfinzi lung cancer drug

The Guardian - UK

Ireland could lose pharma tax to US after Trump accusations, experts warn

Predictions that US firms could retain manufacturing plants in Ireland but move profits back to America

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

CVS is opening more standalone pharmacies after shuttering 1,000 stores

CVS will open a dozen new stores, but they’ll be half the size of a typical location

The Independent UK

Raspberry Pi powers briefcase-sized PiEEG 'Bio Lab' project

Blink twice to control the robot arm

Tom’s Hardware

Why neurohacking is the new biohacking

Brain training just got an upgrade: neurohacking is the latest wellness microtrend, but is there a way to do it without breaking the bank?

Evening Standard

Marjorie Taylor Greene Claims 'Bio Labs' in Ukraine Are Using 'Dr. Frankenstein Science' to Create Diseases and Vaccines

Rep. Marjorie Taylor Greene weighed in on a mystery disease outbreak, suggesting global bio labs, including in Ukraine, are sinisterly engineering diseases.

Latin Times

Skip NVIDIA — Why AMD’s new gaming GPU is my next upgrade, and why it should be yours, too

AMD revealed its next-gen RDNA 4 graphics cards, and the info available so far is enough for me to make a final decision on my next PC upgrade.

Windows Central

British pharma company GSK pauses diversity work citing Trump orders

London-based FTSE 100 firm reviewing its policies, saying it is obliged to comply because US is its No 1 market

The Guardian - UK

Covid inquiry to hear evidence about Michelle Mone-linked firm in private

Chair rules that details about PPE contracts given to company linked to Tory peer will be heard in closed session

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

The war on kush: The synthetic drug sweeping through parts of Africa

A new report by an anti-transnational crime group has identified the core chemical components of kush, a synthetic drug that has swept through Sierra Leone and the region in the past few years.

The Independent UK

The Latest: Musk renews threat to fire federal workers despite pushback from various agencies

Elon Musk is vowing yet again to fire any federal workers who don’t respond to an email asking them to list five things they accomplished last week

Dynamite News

Biological E Limited partners with Bavarian Nordic to increase global access to Chikungunya Vaccine

This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya Vaccine, with the option to transfer the drug substance process at a later stage. Read further on Dynamite News:

Evening Standard

Why has Unilever CEO Hein Schumacher stepped down and who is replacing him?

Mr Schumacher was named CEO in 2023 following the retirement of Alan Jope but has now stepped down in a surprise move

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Pharmaceutical Stocks With Blockbuster Drug Potential

The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors might consider adding three well-positioned biotech stocks such as Vertex Pharmaceuticals (VRTX), BioMarin Pharmaceutical (BMRN), and Gilead Sciences (GILD), for potential gains. Learn more….

StockNews.com

3 Biotech Stocks Revolutionizing Healthcare

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and transformative partnerships. To capitalize on this trend, consider adding Amgen (AMGN), BioNTech (BNTX), and Gilead Sciences (GILD), which could boost your portfolio.

Salon

Is a new painkiller too good to be true?

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids

The Guardian - UK

AstraZeneca, Whitehall, and a failed £450m deal for the next generation in vaccines. What went wrong?

When the pharma firm cancelled plans for a major expansion of its Merseyside plant last month, there was no shortage of questions – or blame – over responsibility

Kiplinger

Eli Lilly Stock Rises After Profit, Outlook Top Expectations

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 guidance. Here's what you need to know.

The Independent UK

AstraZeneca ‘very disappointed’ after ditching £450m Liverpool vaccine site

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision.

StockNews.com

Is Harmony Biosciences Holdings Inc. (HRMY) a Biotech Stock to Consider?

Harmony Biosciences’ (HRMY) recently released growth plans and pipeline advancements have showcased the company’s dedication towards being a top contender in the highly contested biotech market. So, should investors looking to capitalize on the industry’s prospects consider investing in HRMY? Read more….

1 … 24 25 26 27

People

Marjorie Taylor Greene

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.